Product Information
CEFTRIAXONE 500 MG VIAL is a generic product labeled by Apotex Corp., priced at $1.8422 per EA under NDC 60505615204. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 29, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
500 mg/1
Manufacturer
Apotex Corp.NDC
60505615204
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203702FDA Approved
6/29/2016
TE Code
AP
On Market Since
6/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 500 MG VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8422 per EA |
|---|---|
| All-time high | $1.9908 (Nov 12, 2025) |
| All-time low | $1.5280 (Apr 17, 2024) |
| 52-week high | $1.9908 |
| 52-week low | $1.7859 |
| Median price | $1.8660 |
| Average price | $1.8348 |
| Largest weekly change | +14.4% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ceftriaxone Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 500 MG VIAL, manufactured by Apotex Corp., is $1.8422 per EA (NDC 60505615204), effective Sep 30, 2026.
How has the price of CEFTRIAXONE 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 500 MG VIAL has risen 20.6%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 500 MG VIAL?
Since Apr 17, 2024, the NADAC for CEFTRIAXONE 500 MG VIAL has ranged from a low of $1.5280 (Apr 17, 2024) to a high of $1.9908 (Nov 12, 2025), with a median of $1.8660 per EA.
Are there cheaper alternatives to CEFTRIAXONE 500 MG VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFTRIAXONE 500 MG VIAL, is $1.3139 per EA — about 29% below CEFTRIAXONE 500 MG VIAL.
Who manufactures CEFTRIAXONE 500 MG VIAL?
CEFTRIAXONE 500 MG VIAL (NDC 60505615204) is labeled by Apotex Corp., and CMS classifies it as a generic product.